Pharma: Page 36
-
Jonathan Ross via Getty Images
Pharma giants take on Appalachian cancer rates in newest screening initiative
AstraZeneca and Bristol Myers Squibb are teaming up with the nonprofit Association of Community Cancer Centers to increase lung cancer screening in rural Appalachia for the long haul.
By Karissa Waddick • June 7, 2022 -
Permission granted by David Jimenez.
Q&A // First 90 DaysFirst 90 Days: Janssen Immunology’s David Jimenez
The long-time company man discusses the mega-drugmaker’s plans for growth and why, if you meet with him, you should plan on sipping coffee.
By Taren Grom • June 6, 2022 -
Explore the Trendline➔
Stock via Getty Images
TrendlineClinical trial diversity
As pharma wises up to the fact that the current playbook for improving clinical trial diversity has yet to make a meaningful impact, the quest is on to refine that approach.
By PharmaVoice staff -
Permission granted by Merck/Eric Rubin
How to build a cancer pipeline: Big Pharma oncology heads on driving science forward
Executives leading the cancer departments at J&J, Merck and Takeda chime in on what it takes to construct a successful and sustainable oncology drug pipeline.
By Michael Gibney • June 6, 2022 -
iStock via Getty Images
Aduhelm’s Medicare woes leave questions about lofty premiums
A single drug’s effect on the premiums that Medicare beneficiaries pay is raising questions about how these levels are set and what factors play a part.
By Kelly Bilodeau • June 2, 2022 -
Permission granted by Flagship Pioneering/Avak Kahvejian.
ProfileFlagship’s creative approach to finding the next big idea in biopharma
Avak Kahvejian, partner at Flagship Pioneering, a company that conceives, creates and launches bioplatform companies like Moderna, discusses its latest venture, ProFound Therapeutics.
By Alexandra Pecci • June 1, 2022 -
iStock via Getty Images
Cell and gene therapy advances coming fast and furious
A peek into R&D at the Mass General Brigham network reveals up-and-coming treatments pushing the boundaries of what’s possible in medicine.
By Kelly Bilodeau • June 1, 2022 -
Stock via Getty Images
SIGA prepares to kick production for monkeypox treatment into high gear
‘We’re not bored,’ the company’s science chief says as SIGA Technologies looks to ramp up supplies of its therapeutic.
By Meagan Parrish • May 31, 2022 -
Permission granted by Sosei Heptares/Chris Cargill
Q&A // First 90 DaysFirst 90 Days: Sosei Heptares’ Chris Cargill
The company’s new CEO is looking to drive growth through collaboration and transparency.
By Kim Ribbink • May 31, 2022 -
George Marks via Getty Images
PBMs under fire for drug prices defend their worth
A new Senate bill is putting PBMs in the crosshairs of lawmakers — but they argue that they’re more than just middlemen.
By Michael Gibney • May 26, 2022 -
iStock via Getty Images
Making MovesMaking moves: Inovio, Veru, MindMed and more announce key new hires
The latest career moves in the biopharma industry from Veru, MindMed, Horizon Therapeutics and Inovio.
By Karissa Waddick • May 25, 2022 -
Diego Camargo/PharmaVoice
Podcast
Woman of the Week: Ferring Pharmaceutical’s Araz Raoof
Growing up in Iraqi Kurdistan, Raoof says a ‘lethal combination’ of books and strong women paved her way into STEM.
By Taren Grom • May 25, 2022 -
AndreyPopov via Getty Images
Pharmas can be ‘more than medicine’ by focusing on preventative care
Why pharma companies are changing their tack to become more than the products they sell.
By Michael Gibney • May 24, 2022 -
sturti via Getty Images
Sponsored by ClinicalMind3 things medical communications can learn from sales training experts
Medical communications is moving toward more modern approaches that can make critical information more engaging and better able to “stick”.
May 23, 2022 -
Permission granted by Vidya Viswanathan
Tracking trends in healthcare, from tech to patient care
High-performing leaders honored by the Healthcare Businesswomen’s Association share their views on the future of the industry.
By Taren Grom • May 20, 2022 -
iStock via Getty Images
Q&AIronwood Pharmaceuticals is charting a course to become a giant in GI
Ironwood’s CEO, Tom McCourt, discusses the company’s strategy for leveling up in the GI market.
By Karissa Waddick • May 19, 2022 -
John Moore via Getty Images
A potential COVID-19 EUA could turn this small biotech into a household name
Veru’s CEO discusses the impact of the upcoming FDA decision on its treatment targeting severely ill COVID-19 patients.
By Meagan Parrish • May 19, 2022 -
Permission granted by SpringWorks/Jim Cassidy
ProfileJumping into pharma with big plans at a small company
SpringWorks Therapeutics’ chief medical officer on the ambition that drives him and his company to develop treatments for cancer patients.
By Alexandra Pecci • May 17, 2022 -
Spencer Platt via Getty Images
Q&ABriOri BioTech sets the stage for the comeback of Vioxx
With a topical pain-relieving ointment in development, the emerging biotech is aiming to give the tarnished NSAID a new life.
By Kelly Bilodeau • May 17, 2022 -
Stock via Getty Images
Are digital DCTs the answer for rare diseases?
How data from EHRs is helping to identify, diagnose and recruit patients to decentralized clinical trials.
By Kim Ribbink • May 16, 2022 -
iStock via Getty Images
After 40 years, researchers discover new frontiers in the fight against HIV
Medical advances in the last two decades may now provide scientists with the right toolbox to target the long-elusive virus.
By Karissa Waddick • May 16, 2022 -
Westend61 via Getty Images
Sponsored by GoodRxA better approach to boosting patient engagement
GoodRx solutions help biopharma brands overcome common barriers & increase patient engagement.
May 16, 2022 -
Sophia Sharp-Donaldson, executive director, Global Strategic Sourcing and Procurement, Kite Pharma and one of this year’s HBA Luminary honorees.
OpinionWhy ‘soft’ skills matter in the new era of leadership
Standout leaders honored by the Healthcare Businesswomen’s Association discuss the rising value of the interpersonal approach.
By Taren Grom • May 12, 2022 -
Diego Camargo/PharmaVoice
Podcast
Woman of the Week: AiCure’s Michelle Marlborough
As chief product officer at AiCure, Michelle Marlborough is focused on solving tough patient challenges through technology.
By Taren Grom • May 11, 2022 -
Stock via Getty Images
In the hot pharma talent market, execs battle these recruitment misconceptions
One of the top recruiting firms in life sciences weighs in on how companies can attract the next wave of rising stars.
By Meagan Parrish • May 11, 2022 -
iStock via Getty Images
It’s time to acknowledge access as a prescribing barrier
A new survey reveals how red tape limits patient access to doctor-preferred specialty drugs.
By Karissa Waddick • May 11, 2022
Previous
